Neuphoria Therapeutics's total assets for Q3 2024 were AU$30.71M, an increase of 69.05% from the previous quarter. NEUP total liabilities were AU$4.72M for the fiscal quarter, a 6.70% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.